Relapsing allergic bronchopulmonary aspergillosis as a trigger for Kounis syndrome: a case report - Report - MDSpire

Relapsing allergic bronchopulmonary aspergillosis as a trigger for Kounis syndrome: a case report

  • By

  • Haolei Wei

  • Liyan Wu

  • Bin Ni

  • Jingyu Zhang

  • Mengxia Xu

  • Liang Guo

  • Yanping Mao

  • June 9, 2026

  • 0 min

Share

Clinical Report: Kounis Syndrome Induced by Relapsing Allergic Bronchopulmonary Aspergillosis

Overview

This case study describes a 77-year-old woman who developed Kounis syndrome during a relapse of allergic bronchopulmonary aspergillosis (ABPA). Key findings include marked eosinophilia, elevated total IgE, and myocardial injury, highlighting the potential cardiovascular implications of ABPA exacerbations.

Background

Kounis syndrome is an allergic acute coronary syndrome that can be triggered by hypersensitivity reactions, yet it remains underdiagnosed in clinical practice. Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity disorder that can lead to significant pulmonary complications, and its association with Kounis syndrome is rarely reported. Understanding this relationship is crucial for timely diagnosis and management in patients with severe allergic airway diseases.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

  • A 77-year-old woman with asthma and COPD developed Kounis syndrome during an ABPA relapse.
  • Laboratory tests revealed marked eosinophilia and elevated total IgE levels.
  • Myocardial injury was evidenced by increased cardiac troponin I and B-type natriuretic peptide levels.
  • Electrocardiography showed ischemic changes, while coronary angiography indicated nonobstructive coronary arteries.
  • The patient improved with antifungal therapy, systemic corticosteroids, and coronary vasodilators.

Clinical Implications

Healthcare professionals should maintain a high index of suspicion for Kounis syndrome in patients with ABPA who present with unexplained cardiopulmonary symptoms. Early recognition and appropriate management of both the allergic process and myocardial ischemia are essential.

Conclusion

This case underscores the potential for ABPA to trigger Kounis syndrome, emphasizing the need for cardiovascular vigilance in patients with severe allergic airway diseases.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Kounis Syndrome Induced by Relapsing Allergic Bronchopulmonary Aspergillosis: A Case Study
  2. Frontiers in Pediatrics — Case Report: Atypical pediatric allergic bronchopulmonary aspergillosis masquerading as recurrent pneumonia
  3. Frontiers in Medicine — Multimodal interventional bronchoscopy for chronic pulmonary Aspergillus infection with post-tubercular bronchial occlusion: a case report
  4. Infection — Lethal pulmonary hemorrhage, pneumothorax, and skin necrosis due to Immune Reconstitution Inflammatory Syndrome in a young individual with agranulocytosis linked to metamizole and Aspergillus flavus infection
  5. Frontiers in Medicine — Case Report: Invasive pulmonary aspergillosis caused by Aspergillus lentulus in a boy with chronic granulomatous disease
  6. Kounis Syndrome: Review of Clinical Cases
  7. Triggers, Types, and Treatments for Kounis Syndrome: A Systematic Review
  8. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
  9. Type I Kounis syndrome in a young woman without chest pain: a case report | BMC Cardiovascular Disorders | Springer Nature Link
  10. Triggers, Types, and Treatments for Kounis Syndrome: A Systematic Review
  11. Frontiers | Case Report: Anaphylactic shock and ST-elevation myocardial infarction following a bee sting: two deadly diseases in a patient with Kounis syndrome
  12. Anaphylaxis in Practice: A Guide to the 2023 Practice Parameter Update - PubMed
  13. Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses - PMC
  14. Dupilumab efficacy in patients with asthma and allergic bronchopulmonary aspergillosis (ABPA) | European Respiratory Society
  15. Dupilumab Improves Lung Function and
  16. ERS Congress 2025: highlights from the Airway Diseases Assembly | European Respiratory Society
  17. Allergic Bronchopulmonary Aspergillosis - StatPearls - NCBI Bookshelf

Original Source(s)

Related Content